Related references
Note: Only part of the references are listed.Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers
Adel Alblihy et al.
NPJ BREAST CANCER (2021)
Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer
Caglar Berkel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Chromatin-associated MRN complex protects highly transcribing genes from genomic instability
Kader Salifou et al.
SCIENCE ADVANCES (2021)
Synthetic lethality as an engine for cancer drug target discovery
Alan Huang et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
DNA-dependent protein kinase promotes DNA end processing by MRN and CtIP
Rajashree A. Deshpande et al.
SCIENCE ADVANCES (2020)
Human RAD50 deficiency: Confirmation of a distinctive phenotype
Aviel Ragamin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2020)
ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion
Demis Menolfi et al.
CELL AND BIOSCIENCE (2020)
CtIP promotes the motor activity of DNA2 to accelerate long-range DNA end resection
Ilaria Ceppi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors
Adewale Oluwaseun Fadaka et al.
CANCERS (2020)
Roles ofChk2/CHEK2in guarding against environmentally inducedDNAdamage and replication-stress
Md. Kawsar Mustofa et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2020)
NBS1 promotes the endonuclease activity of the MRE11-RAD50 complex by sensing CtIP phosphorylation
Roopesh Anand et al.
EMBO JOURNAL (2019)
MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
Yiling Situ et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ataxia-telangiectasia: A review of clinical features and molecular pathology
Parisa Amirifar et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2019)
Comparison of Predictive In Silico Tools on Missense Variants in GJB2, GJB6, and GJB3 Genes Associated with Autosomal Recessive Deafness 1A (DFNB1A)
Vera G. Pshennikova et al.
TheScientificWorldJOURNAL (2019)
Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect
Alice Fievet et al.
HUMAN MUTATION (2019)
Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing
Jenny Chang et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
Georgios N. Tsaousis et al.
BMC CANCER (2019)
C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex
Yongtai Bai et al.
MOLECULAR CELL (2019)
Mechanism of DNA End Sensing and Processing by the Mre11-Rad50 Complex
Lisa Kaeshammer et al.
MOLECULAR CELL (2019)
MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
Lei Bian et al.
MOLECULAR CANCER (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Processing of DNA Double-Strand Breaks by the MRX Complex in a Chromatin Context
Erika Casari et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Elevated MRE11 expression associated with progression and poor outcome in prostate cancer
Jun Wang et al.
JOURNAL OF CANCER (2019)
Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma
Raman Kumar et al.
LEUKEMIA & LYMPHOMA (2018)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
C. Cruz et al.
ANNALS OF ONCOLOGY (2018)
DNA Repair: The Search for Homology
James E. Haber
BIOESSAYS (2018)
DNA Damage, Mutagenesis and Cancer
Ashis K. Basu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ataxia-Telangiectasia: A Review of Movement Disorders, Clinical Features, and Genotype Correlations
Ariel Levy et al.
MOVEMENT DISORDERS (2018)
MicroRNA regulation of the MRN complex impacts DNA damage, cellular senescence, and angiogenic signaling
Cristina Espinosa-Diez et al.
CELL DEATH & DISEASE (2018)
The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair
Aleem Syed et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
Vincent Ho et al.
BMC CANCER (2018)
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors
Marialaura Petroni et al.
CELL DEATH & DISEASE (2018)
Genomic analysis of DNA repair genes and androgen signaling in prostate cancer
Kasey Jividen et al.
BMC CANCER (2018)
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
Magdalena Koczkowska et al.
CANCERS (2018)
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Isabella Faraoni et al.
CANCERS (2018)
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types
Arielle L. Heeke et al.
JCO PRECISION ONCOLOGY (2018)
Mechanisms of DNA Damage, Repair, and Mutagenesis
Nimrat Chatterjee et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)
RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
Mariam Gachechiladze et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
NBS1 is regulated by two kind of mechanisms: ATM-dependent complex formation with MRE11 and RAD50, and cell cycle-dependent degradation of protein
Hui Zhou et al.
JOURNAL OF RADIATION RESEARCH (2017)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
Synthetic lethality screens point the way to new cancer drug targets
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2017)
The essential kinase ATR: ensuring faithful duplication of a challenging genome
Joshua C. Saldivar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Telomeres and Cell Senescence - Size Matters Not
Stella Victorelli et al.
EBIOMEDICINE (2017)
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer
Simone Brandt et al.
BMC CANCER (2017)
Genetic variations in the homologous recombination repair pathway genes modify risk of glioma
Haishi Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management
Zdenek Kleibl et al.
BREAST (2016)
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
Rossella Graffeo et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Siyuan Zheng et al.
CANCER CELL (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
MRN, CtIP, and BRCA1 mediate repair of topoisomerase II-DNA adducts
Tomas Aparicio et al.
JOURNAL OF CELL BIOLOGY (2016)
NBS1 and multiple regulations of DNA damage response
Kenshi Komatsu
JOURNAL OF RADIATION RESEARCH (2016)
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs
Nancy Berte et al.
MOLECULAR CANCER THERAPEUTICS (2016)
ATM Mutations in Cancer: Therapeutic Implications
Michael Choi et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Phosphorylated CtIP Functions as a Co-factor of the MRE11-RAD50-NBS1 Endonuclease in DNA End Resection
Roopesh Anand et al.
MOLECULAR CELL (2016)
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Eva Seemanova et al.
PLOS ONE (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
Understanding of BRCA VUS genetic results by breast cancer specialists
B. K. Eccles et al.
BMC CANCER (2015)
Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations
Ivone U. S. Leong et al.
BMC MEDICAL GENETICS (2015)
Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer
Camille C. Gunderson et al.
FUTURE ONCOLOGY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
Honglin Song et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
PARP inhibitors: A new era of targeted therapy
Shifalika Tangutoori et al.
MATURITAS (2015)
Interdependence of the Rad50 Hook and Globular Domain Functions
Marcel Hohl et al.
MOLECULAR CELL (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Multigene Panel Testing in Oncology Practice How Should We Respond?
Allison W. Kurian et al.
JAMA ONCOLOGY (2015)
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond et al.
JAMA ONCOLOGY (2015)
Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
Lin Feng et al.
CELL DISCOVERY (2015)
Smad7 enhances ATM activity by facilitating the interaction between ATM and Mre11-Rad50-Nbs1 complex in DNA double-strand break repair
Sujin Park et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor
Martin F. Lavin et al.
BIOMOLECULES (2015)
RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy
Ali Flores-Perez et al.
CANCER BIOLOGY & THERAPY (2014)
Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality
Livnat Jerby-Arnon et al.
CELL (2014)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Dual Disruption of DNA Repair and Telomere Maintenance for the Treatment of Head and Neck Cancer
Shayanne A. Lajud et al.
CLINICAL CANCER RESEARCH (2014)
RAD50 phosphorylation promotes ATR downstream signaling and DNA restart following replication stress
Magtouf Gatei et al.
HUMAN MOLECULAR GENETICS (2014)
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants
Sara Gutierrez-Enriquez et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
DNA Double-Strand Break Repair Pathway Choice Is Directed by Distinct MRE11 Nuclease Activities
Atsushi Shibata et al.
MOLECULAR CELL (2014)
PALB2 Mutations and Breast-Cancer Risk
Michele K. Evans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro
Romana Koppensteiner et al.
PLOS ONE (2014)
Identification of the Interactors of Human Nibrin (NBN) and of Its 26 kDa and 70 kDa Fragments Arising from the NBN 657del5 Founder Mutation
Domenica Cilli et al.
PLOS ONE (2014)
Synthetic Lethality in ATM-Deficient RAD50-Mutant Tumors Underlies Outlier Response to Cancer Therapy
Hikmat Al-Ahmadie et al.
CANCER DISCOVERY (2014)
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
Francesca Damiola et al.
BREAST CANCER RESEARCH (2014)
Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms
Joshua A. Regal et al.
HUMAN MOLECULAR GENETICS (2013)
Ataxia Telangiectasia-Mutated (ATM) Kinase Activity Is Regulated by ATP-driven Conformational Changes in the Mre11/Rad50/Nbs1 (MRN) Complex
Ji-Hoon Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair
Lin Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Cell Cycle-Dependent Regulatory Circuit Composed of 53BP1-RIF1 and BRCA1-CtIP Controls DNA Repair Pathway Choice
Cristina Escribano-Diaz et al.
MOLECULAR CELL (2013)
DNA Damage Sensing by the ATM and ATR Kinases
Alexandre Marechal et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
BRCA1 in the DNA damage response and at telomeres
Eliot M. Rosen
Frontiers in Genetics (2013)
Germ line Mutation in ATR in Autosomal-Dominant Oropharyngeal Cancer Syndrome
Akio Tanaka et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1
Songmin Ying et al.
CANCER RESEARCH (2012)
Mechanisms for recurrent and complex human genomic rearrangements
Pengfei Liu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
Response to DNA damage of CHEK2 missense mutations in familial breast cancer
Wendy Roeb et al.
HUMAN MOLECULAR GENETICS (2012)
Mre11 modulates the fidelity of fusion between short telomeres in human cells
Maira Tankimanova et al.
NUCLEIC ACIDS RESEARCH (2012)
Genetic Interactions in Cancer Progression and Treatment
Alan Ashworth et al.
CELL (2011)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence
Ben Zhang et al.
LANCET ONCOLOGY (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
The MRE11 complex: starting from the ends
Travis H. Stracker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The Rad50 coiled-coil domain is indispensable for Mre11 complex functions
Marcel Hohl et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1
Verena Quennet et al.
NUCLEIC ACIDS RESEARCH (2011)
Crystal Structure of Human Mre11: Understanding Tumorigenic Mutations
Young Bong Park et al.
STRUCTURE (2011)
Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells
C. V. Kavitha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer
K. Araki et al.
BRITISH JOURNAL OF CANCER (2010)
Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks
Gareth J. Williams et al.
DNA REPAIR (2010)
The MRN complex in double-strand break repair and telomere maintenance
Brandon J. Lamarche et al.
FEBS LETTERS (2010)
Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function Mutations
Sarah E. Flanagan et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2010)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Human RAD50 Deficiency in a Nijmegen Breakage Syndrome-like Disorder
Regina Waltes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Exploiting synthetic lethal interactions for targeted cancer therapy
H. Christian Reinhardt et al.
CELL CYCLE (2009)
Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy
Waleed M. Abuzeid et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Meiotic DNA Double-Strand Break Repair Requires Two Nucleases, MRN and Ctp1, To Produce a Single Size Class of Rec12 (Spo11)-Oligonucleotide Complexes
Neta Milman et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Fan Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
Distinct Requirements for the Rad32Mre11 Nuclease and Ctp1CtIP in the Removal of Covalently Bound Topoisomerase I and II from DNA
Edgar Hartsuiker et al.
MOLECULAR CELL (2009)
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Zhenjian Cai et al.
MOLECULAR CELL (2009)
Multiple roles for MRE11 at uncapped telomeres
Yibin Deng et al.
NATURE (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells
Emilie Rass et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair
R. Scott Williams et al.
CELL (2008)
Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation
Jeffrey Buis et al.
CELL (2008)
Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair
Longchuan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex
Aude Dupre et al.
NATURE CHEMICAL BIOLOGY (2008)
Systematic discovery of in vivo phosphorylation networks
Rune Linding et al.
CELL (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks
Haruyuki Takemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit
Van Leung-Pineda et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
ATM and breast cancer susceptibility
M. Ahmed et al.
ONCOGENE (2006)
Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis
A Kurose et al.
CYTOMETRY PART A (2005)
Endonucleolytic processing of covalent protein-linked DNA double-strand breaks
MJ Neale et al.
NATURE (2005)
ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1
ZS You et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cancer risks and mortality in heterozygous ATM mutation carriers
D Thompson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Endogenous DNA damage in humans: a review of quantitative data
R De Bont et al.
MUTAGENESIS (2004)
Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex
JH Lee et al.
SCIENCE (2004)
The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38γ-independent pathway
E Tosti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1
O Fernandez-Capetillo et al.
NATURE CELL BIOLOGY (2002)
Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase
KP Hopfner et al.
CELL (2001)
An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele
RS Maser et al.
NATURE GENETICS (2001)
Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily
KP Hopfner et al.
CELL (2000)
Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products
S Zhao et al.
NATURE (2000)
Share Paper
